Influence of fluvastatin on levels of von Willebrand factor in cardiac transplant recipients
Blann, A.D.
Thrombosis and Haemostasis 84(3): 514
2000
ISSN/ISBN: 0340-6245 PMID: 11019980 Document Number: 518957
Document emailed within 1 workday
Related Documents
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274Degré, S.G. 1993: Are cardiac transplant recipients still suffering cardiac failure? Acta Cardiologica 48(1): 1-9
Patel, V.S.; Lim, M.; Massin, E.K.; Jonsyn, G.P.; Ates, P.; Abou-Awdi, N.L.; McAllister, H.A.; Radovancevic, B.; Frazier, O.H. 1996: Sudden cardiac death in cardiac transplant recipients Circulation 94(9): II273-II277
Brinkhous, K.M.; Thomas, B.D.; Ibrahim, S.A.; Read, M.S. 1977: Plasma levels of platelet aggregating factor/vom Willebrand factor in various species Thrombosis Research 11(3): 345-355
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Lu, G-yuan.; Shen, L.; Wang, Z-yue.; Guo, X-fang.; Bai, X.; Su, J.; Ruan, C-geng. 2008: Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chinese Medical Journal 121(2): 133-136
Girma, J.P.; Pietu, G.; Lavergne, J.M.; Meyer, D.; Larrieu, M.J. 1982: Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease Journal of Laboratory and Clinical Medicine 99(4): 481-494
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Sanda, M.G.; Pierson, R.; Smith, C.; Reemtsma, K.; Rose, E. 1989: Serum dipeptidyl peptidase IV in cardiac transplant recipients Transplantation Proceedings 21(1 Part 3): 2525-2526
Kottke-Marchant, K.; Ratliff, N.B. 1990: Endomyocardial biopsy. Pathologic findings in cardiac transplant recipients Pathology Annual 25 Pt 1: 211-244
Radovancevic, B.; Birovljev, S.; Frazier, O.H.; Duncan, J.M.; Bennink, W.; Sweeney, M.S.; McAllister, H.A.; Burnett, C.M.; Vega, J.D.; Lonquist, J.L. 1990: Long-term follow-up of cyclosporine-treated cardiac transplant recipients Transplantation Proceedings 22(3 Suppl 1): 21-24
Meyer, D.; Obert, B.; Pietu, G.; Lavergne, J.M.; Zimmerman, T.S. 1980: Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease Journal of Laboratory and Clinical Medicine 95(4): 590-602
Merkel, U.; Lindner, S.; Vollandt, R.; Sperschneider, H.; Balogh, A. 2005: Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients International Journal of Clinical Pharmacology and Therapeutics 43(8): 379-388
Page, B.; Morin, M.P.; Mamzer, M.F.; Thervet, E.; Legendre, C. 1994: Use of granulocyte-macrophage colony-stimulating factor in leukopenic renal transplant recipients Transplantation Proceedings 26(1): 283
Gibbons, S.; Grevel, J.; Reynolds, K.; Ried, M.; Rutzky, L.P.; Kahan, B.D. 1988: Comparison and correlation of assays for monitoring cyclosporine drug levels in renal transplant recipients Transplantation Proceedings 20(2 Suppl 2: 339-344
Van der Heyden, A.A.; van Oers, M.H.; Cornelissen, P.; Yong, S.L.; Wilmink, J.M.; Schellekens, P.T. 1988: The influence of cyclosporine a treatment on immune responsiveness in vitro and in vivo in kidney transplant recipients Transplantation Proceedings 20(2 Suppl 2: 190-195
Hughes, J.R.; Hughes, V.F.; Trull, A.K.; Metcalfe, S.M. 1999: Blood levels of TGFbeta1 in liver transplant recipients receiving either tacrolimus or micro-emulsified cyclosporine Transplantation 68(4): 583-586
Rymarz, A.; Durlik, M.; Rydzewski, A. 2009: Intravenous administration of N-acetylcysteine reduces plasma total homocysteine levels in renal transplant recipients Annals of Transplantation 14(4): 5-9
Hricik, D.E.; Bartucci, M.R.; Moir, E.J.; Mayes, J.T.; Schulak, J.A. 1991: Influence of corticosteroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients Transplantation Proceedings 23(1 Pt 2): 1007-1008
Mohanakumar, T.; Hoshinaga, K.; Wood, N.L.; Szentpetery, S.; Lower, R.R. 1986: Enumeration of transferrin-receptor-expressing lymphocytes as a potential marker for rejection in human cardiac transplant recipients Transplantation 42(6): 691-694